Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis.

OBJECTIVE: To describe a distinctive seizure semiology that closely associates with voltage-gated potassium channel (VGKC)-complex/Lgi1 antibodies and commonly precedes the onset of limbic encephalitis (LE). METHODS: Twenty-nine patients were identified by the authors (n = 15) or referring clinicians (n = 14). The temporal progression of clinical features and serum sodium, brain magnetic resonance imaging (MRI), positron emission tomography/single photon emission computed tomography, and VGKC-complex antibodies was studied. RESULTS: Videos and still images showed a distinctive adult-onset, frequent, brief dystonic seizure semiology that predominantly affected the arm and ipsilateral face. We have termed these faciobrachial dystonic seizures (FBDS). All patients tested during their illness had antibodies to VGKC complexes; the specific antigenic target was Lgi1 in 89%. Whereas 3 patients never developed LE, 20 of the remaining 26 (77%) experienced FBDS prior to the development of the amnesia and confusion that characterize LE. During the prodrome of FBDS alone, patients had normal sodium and brain MRIs, but electroencephalography demonstrated ictal epileptiform activity in 7 patients (24%). Following development of LE, the patients often developed other seizure semiologies, including typical mesial temporal lobe seizures. At this stage, investigations commonly showed hyponatremia and MRI hippocampal high T2 signal; functional brain imaging showed evidence of basal ganglia involvement in 5/8. Antiepileptic drugs (AEDs) were generally ineffective and in 41% were associated with cutaneous reactions that were often severe. By contrast, immunotherapies produced a clear, and often dramatic, reduction in FBDS frequency. INTERPRETATION: Recognition of FBDS should prompt testing for VGKC-complex/Lgi1 antibodies. AEDs often produce adverse effects; treatment with immunotherapies may prevent the development of LE with its potential for cerebral atrophy and cognitive impairment

Bariatric Surgery and Its Effects on the Skin and Skin Diseases

In light of the increasing prevalence of obesity worldwide, the popularity of bariatric surgery is on the rise. As with any other invasive procedure, these surgeries, especially with the obesity risk factor, carry the risk of direct cutaneous complications following the penetration and manipulation of tissues. In addition, bariatric surgery has an effect on skin structure and function. It also appears to be affiliated with several dermatoses. Some of these represent preexisting diseases the course of which is altered by the procedure, such as psoriasis. On the other hand, other skin disorders are triggered by the surgery itself. This article reviews and summarizes these cutaneous effects and complications. © 2013 Springer Science+Business Media New York.Alasfar F, 2010, OBES SURG, V20, P168, DOI 10.1007-s11695-008-9708-3; Araco A, 2007, OBES SURG, V17, P828, DOI 10.1007-s11695-007-9126-y; Ashourian N, 2006, NEW ENGL J MED, V354, P1614, DOI 10.1056-NEJMicm050641; Ballinger S, 2003, CURR OPIN RHEUMATOL, V15, P591, DOI 10.1097-00002281-200309000-00012; BARR DJ, 1984, ARCH DERMATOL, V120, P919, DOI 10.1001-archderm.120.7.919; Biorserud C, 2011, OBES SURG, V21, P273, DOI 10.1007-s11695-009-9849-z; Bleasel NR, 1999, J AM ACAD DERMATOL, V41, P322, DOI 10.1016-S0190-9622(99)70375-0; Bobowicz M, 2011, OBES SURG, V21, P1843, DOI 10.1007-s11695-011-0403-4; Brolin RE, 1996, AM J SURG, V172, P328, DOI 10.1016-S0002-9610(96)00194-8; Brouard MC, 2004, J EUR ACAD DERMATOL, V18, P89, DOI 10.1111-j.1468-3083.2004.00712.x; Bussolaro RA, 2012, OBES SURG, V22, P353, DOI 10.1007-s11695-011-0485-z; Callen JP, 2002, DERMATOL CLIN, V20, P409, DOI 10.1016-S0733-8635(02)00006-2; Cone LA, 2004, OBES SURG, V14, P690, DOI 10.1381-096089204323093507; Danese C, 2011, CLIN TER, V162, pE89; de Jongh RT, 2008, MICROVASC RES, V75, P256, DOI 10.1016-j.mvr.2007.08.001; D'Ettorre M, 2010, OBES SURG, V20, P1552, DOI 10.1007-s11695-010-0224-x; DICKEN CH, 1986, J AM ACAD DERMATOL, V14, P792, DOI 10.1016-S0190-9622(86)70095-9; Dumon KR, 2011, SURG CLIN N AM, V91, P1313, DOI 10.1016-j.suc.2011.08.014; ELY PH, 1980, J AM ACAD DERMATOL, V2, P473; Ettinger JEMTM, 2006, OBES SURG, V16, P94; Farias MM, 2012, OBES SURG, V22, P877, DOI 10.1007-s11695-012-0646-8; Faurschou A, 2011, MED HYPOTHESES, V77, P1098, DOI 10.1016-j.mehy.2011.09.011; Fisch C, 2001, RHEUMATOLOGY, V40, P351, DOI 10.1093-rheumatology-40.3.351; Folope V, 2007, GASTROEN CLIN BIOL, V31, P369, DOI 10.1016-S0399-8320(07)89395-X; Freeman JT, 2011, OBES SURG, V21, P836, DOI 10.1007-s11695-010-0105-3; GAMBLE CN, 1982, AM J CLIN PATHOL, V77, P347; Garcia H. L., 2002, AM J CLIN DERMATOL, V3, P497; Girard C, 2006, PEDIATR DERMATOL, V23, P346, DOI 10.1111-j.1525-1470.2006.00261.x; Goldberg LJ, 2010, CLIN DERMATOL, V28, P412, DOI 10.1016-j.clindermatol.2010.03.038; GOLDMAN JA, 1979, ARCH DERMATOL, V115, P725, DOI 10.1001-archderm.115.6.725; Hamminga EA, 2006, MED HYPOTHESES, V67, P768, DOI 10.1016-j.mehy.2005.11.050; Herron MD, 2005, ARCH DERMATOL, V141, P1527, DOI 10.1001-archderm.141.12.1527; Higa-Sansone G, 2004, OBES SURG, V14, P1132, DOI 10.1381-0960892041975569; Hossler EW, 2011, J AM ACAD DERMATOL, V65, P198, DOI 10.1016-j.jaad.2010.01.001; Hossler EW, 2013, BRIT J DERMATOL, V168, P660, DOI 10.1111-j.1365-2133.2012.11211.x; Jonk AM, 2007, PHYSIOLOGY, V22, P252, DOI 10.1152-physiol.00012.2007; JORIZZO JL, 1983, ARCH INTERN MED, V143, P457, DOI 10.1001-archinte.143.3.457; Karmali S, 2010, CAN FAM PHYSICIAN, V56, P873; Katsuki A, 1998, J CLIN ENDOCR METAB, V83, P859, DOI 10.1210-jc.83.3.859; Katugampola RP, 2004, CLIN EXP DERMATOL, V29, P261, DOI 10.1111-j.1365-2230.2004.01476.x; Kovaleski CR, 1997, ARCH DERMATOL, V133, P113; Lewandowski Helen, 2007, Endocr Pract, V13, P277; Light D, 2010, PLAST RECONSTR SURG, V125, P343, DOI 10.1097-PRS.0b013e3181c2a657; LINDEGARD B, 1986, DERMATOLOGICA, V172, P298; Lopez JF, 2000, ANN CHIR, V125, P297, DOI 10.1016-S0001-4001(00)00135-5; Maronn M, 2005, PEDIATR DERMATOL, V22, P60, DOI 10.1111-j.1525-1470.2005.22113.x; Mason EE, 1992, AM J CLIN NUTR, V55, p537S; Maverakis Emanual, 2007, Dermatol Online J, V13, P11; Michaels J, 2011, PLAST RECONSTR SURG, V127, P1693, DOI 10.1097-PRS.0b013e31820a649f; Moreira Mde A, 2010, ACTA GASTROENTEROL L, V40, P244; Nadler EP, 2007, J PEDIATR SURG, V42, P137, DOI 10.1016-j.jpedsurg.2006.09.014; Naldi L, 2005, J INVEST DERMATOL, V125, P61, DOI 10.1111-j.0022-202X.2005.23681.x; National Institutes of Health, 2012, GASTR SURG SEV OB; Neve HJ, 1996, OBES SURG, V6, P63, DOI 10.1381-096089296765557295; Ocon J, 2012, JPEN-PARENTER ENTER, V36, P361, DOI 10.1177-0148607111422067; Orpheu SC, 2010, OBES SURG, V20, P480, DOI 10.1007-s11695-009-0019-0; Papavramidis ST, 1999, OBES SURG, V9, P535, DOI 10.1381-096089299765552620; Patton Timothy, 2009, Dermatol Online J, V15, P3; Perez-Perez L, 2009, CLIN EXP DERMATOL, V34, pe421, DOI 10.1111-j.1365-2230.2009.03406.x; PORRES JM, 1977, ARCH DERMATOL, V113, P983; Quigley S, 2011, CLIN RADIOL, V66, P903, DOI 10.1016-j.crad.2011.04.017; Raychaudhuri SP, 2000, CUTIS, V66, P348; Reoch J, 2011, ARCH SURG-CHICAGO, V146, P1314, DOI 10.1001-archsurg.2011.270; Robinson MR, 2011, J AM ACAD DERMATOL, V65, P448, DOI 10.1016-j.jaad.2010.03.004; Rojas P, 2011, NUTR HOSP, V26, P856, DOI [10.1590-S0212-16112011000400028, 10.3305-nh.2011.26.4.5199]; Rossi M, 2011, OBES SURG, V21, P87, DOI 10.1007-s11695-010-0286-9; Rubin M, 2001, OBES SURG, V11, P315, DOI 10.1381-096089201321336674; Setty AR, 2007, ARCH INTERN MED, V167, P1670, DOI 10.1001-archinte.167.15.1670; Shipman AR, 2011, BRIT J DERMATOL, V165, P743, DOI 10.1111-j.1365-2133.2011.10393.x; Shon W, 2011, J CUTAN PATHOL, V38, P560, DOI 10.1111-j.1600-0560.2011.01703.x; Shope TR, 2003, OBES SURG, V13, P355, DOI 10.1381-096089203765887651; Skroubis G, 2011, WORLD J SURG, V35, P93, DOI 10.1007-s00268-010-0816-6; Slater GH, 2004, J GASTROINTEST SURG, V8, P48, DOI 10.1016-j.gassur.2003.09.020; Slater GH, 2004, OBES SURG, V14, P133, DOI 10.1381-096089204772787446; Snow JM, 2011, SURG CLIN N AM, V91, P1249, DOI 10.1016-j.suc.2011.08.008; Stapleton Phoebe A, 2008, Pathophysiology, V15, P79, DOI 10.1016-j.pathophys.2008.04.007; Tu J, 2011, AUSTRALAS J DERMATOL, V52, pE5, DOI 10.1111-j.1440-0960.2009.00614.x; WECHSLER HL, 1979, ARCH DERMATOL, V115, P73, DOI 10.1001-archderm.115.1.73; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172-JCI200320514; WILLIAMS HJ, 1979, ARCH DERMATOL, V115, P1091, DOI 10.1001-archderm.115.9.1091; World Health Organisation (WHO), OB OV; Xanthakos SA, 2009, PEDIATR CLIN N AM, V56, P1105, DOI 10.1016-j.pcl.2009.07.002; Young RJ, 2010, LANCET ONCOL, V11, P983, DOI 10.1016-S1470-2045(10)70023-114